IRIS Accounts Production v25.4.12.37 15797643 director 23.6.24 30.6.25 30.6.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 15797643 2024-06-22 15797643 2025-06-30 15797643 2024-06-23 2025-06-30 15797643 2024-06-22 15797643 ns15:EnglandWales 2024-06-23 2025-06-30 15797643 ns14:PoundSterling 2024-06-23 2025-06-30 15797643 ns10:Director1 2024-06-23 2025-06-30 15797643 ns10:PrivateLimitedCompanyLtd 2024-06-23 2025-06-30 15797643 ns10:SmallEntities 2024-06-23 2025-06-30 15797643 ns10:AuditExemptWithAccountantsReport 2024-06-23 2025-06-30 15797643 ns10:SmallCompaniesRegimeForDirectorsReport 2024-06-23 2025-06-30 15797643 ns10:SmallCompaniesRegimeForAccounts 2024-06-23 2025-06-30 15797643 ns10:FullAccounts 2024-06-23 2025-06-30 15797643 ns10:RegisteredOffice 2024-06-23 2025-06-30 15797643 ns5:CurrentFinancialInstruments 2025-06-30 15797643 ns5:ShareCapital 2025-06-30 15797643 ns5:RetainedEarningsAccumulatedLosses 2025-06-30 15797643 1 2024-06-23 2025-06-30

REGISTERED NUMBER: 15797643 (England and Wales)

SKIN ETC MEDICAL NORTH LTD

Unaudited Financial Statements for the Period 23 June 2024 to 30 June 2025

SKIN ETC MEDICAL NORTH LTD (REGISTERED NUMBER: 15797643)

Contents of the Financial Statements

for the Period 23 June 2024 to 30 June 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

Chartered Accountants' Report | 5 |

SKIN ETC MEDICAL NORTH LTD

Company Information

for the Period 23 June 2024 to 30 June 2025

| DIRECTOR: | Dr D K Dhunna

| REGISTERED OFFICE: | Granville House

| 2 Tettenhall Road

| Wolverhampton

| West Midlands

| WV1 4SB

| REGISTERED NUMBER: | 15797643 (England and Wales)

| ACCOUNTANTS: | Lancaster Haskins Limited

| Granville House

| 2 Tettenhall Road

| Wolverhampton

| West Midlands

| WV1 4SB

SKIN ETC MEDICAL NORTH LTD (REGISTERED NUMBER: 15797643)

Balance Sheet

30 June 2025

| Notes | £ |

| CURRENT ASSETS

| Stocks | 100 |  |

| Debtors | 4 | 1,000 |  |

| Cash at bank | 19,831 |  |

20,931 |  |

| CREDITORS

| Amounts falling due within one year | 5 | 13,330 |  |

| NET CURRENT ASSETS | 7,601 |  |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 7,601 |  |

| CAPITAL AND RESERVES

| Called up share capital | 1,000 |  |

| Retained earnings | 6,601 |  |

7,601 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 February 2026 and were signed by:

Dr D K Dhunna - Director

SKIN ETC MEDICAL NORTH LTD (REGISTERED NUMBER: 15797643)

Notes to the Financial Statements

for the Period 23 June 2024 to 30 June 2025

1. | STATUTORY INFORMATION

| Skin Etc Medical North Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Financial instruments

| A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.

| Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value the future payments discounted at a market rate of interest for a similar debt instrument.

| Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

SKIN ETC MEDICAL NORTH LTD (REGISTERED NUMBER: 15797643)

Notes to the Financial Statements - continued

for the Period 23 June 2024 to 30 June 2025

2. | ACCOUNTING POLICIES - continued

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 1 .

4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Amounts owed by group undertakings | 1,000 |  |

5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Social security and other taxes | 5,941 |  |

| Other creditors | 4,531 |  |

| Directors' current accounts | 714 |  |

| Accrued expenses | 2,144 |  |

13,330 |  |

6. | RELATED PARTY DISCLOSURES

| The balance owed to the director at the end of the year was £714, which is included in creditors.

7. | ULTIMATE CONTROLLING PARTY

| The controlling party is Quantum Delta Holdings Ltd, a company registered in England.

| The ultimate controlling party is Dr. D.K. Dhunna.

Chartered Accountants' Report to the Director

on the Unaudited Financial Statements of

Skin Etc Medical North Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Skin Etc Medical North Ltd for the period ended 30 June 2025 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Skin Etc Medical North Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Skin Etc Medical North Ltd and state those matters that we have agreed to state to the director of Skin Etc Medical North Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Skin Etc Medical North Ltd and its director for our work or for this report.

It is your duty to ensure that Skin Etc Medical North Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Skin Etc Medical North Ltd. You consider that Skin Etc Medical North Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Skin Etc Medical North Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Lancaster Haskins Limited

Granville House

2 Tettenhall Road

Wolverhampton

West Midlands

WV1 4SB

16 February 2026